The <scp>ERK5</scp> pathway in <scp>BRAFV600E</scp> melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenibAnil K. Mondru(University of Liverpool), Michael Cross(University of Liverpool)FEBS LettersJuly 8, 202410.1002/1873-3468.14960Cited by 9SaveCiteExport RISWatch citationsRelated PapersRCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells|Angiogenesis|2017|62VEGF Stimulates RCAN1.4 Expression in Endothelial Cells via a Pathway Requiring Ca2+/Calcineurin and Protein Kinase C-δ|PLoS ONE|2010|42VEGF Stimulates Activation of ERK5 in the Absence of C-Terminal Phosphorylation Preventing Nuclear Localization and Facilitating AKT Activation in Endothelial Cells|Cells|2023|3